157 related articles for article (PubMed ID: 16477926)
1. Gemcitabine-induced radiation necrosis of the pectoralis major muscle.
Horan G; Smith SL; Podd TJ
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):85. PubMed ID: 16477926
[No Abstract] [Full Text] [Related]
2. Radiation myositis: the possible role of gemcitabine.
Ganem G; Solal-Celigny P; Joffroy A; Tassy D; Delpon A; Dupuis O
Ann Oncol; 2000 Dec; 11(12):1615-6. PubMed ID: 11205473
[No Abstract] [Full Text] [Related]
3. [Interstitial lung disease in a patient given gemcitabine].
Hammerer V; Schmitz N; Pauli G; Quoix E
Rev Pneumol Clin; 2002 Feb; 58(1):23-6. PubMed ID: 11981501
[TBL] [Abstract][Full Text] [Related]
4. Sonographic features of pectoralis muscle necrosis secondary to gemcitabine-induced radiation recall: case report and review of current literature.
O'Regan KN; Nishino M; Armand P; Kelly PJ; Hwang DG; Di Salvo D
J Ultrasound Med; 2010 Oct; 29(10):1499-502. PubMed ID: 20876906
[No Abstract] [Full Text] [Related]
5. An unusual case of gemcitabine-induced radiation recall.
Squire S; Chan M; Feller E; Mega A; Gold R
Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
[No Abstract] [Full Text] [Related]
6. [Digital necrosis related to gemcitabine].
Stephan D; Miréa C; Berthillot C; Gaertner S; Welsch M
Presse Med; 2010 Dec; 39(12):1336-8. PubMed ID: 20850265
[No Abstract] [Full Text] [Related]
7. Delayed anemia and thrombocytopenia after treatment with gemcitabine.
Malayeri R; Krajnik G; Ohler L; Pirker R
J Natl Cancer Inst; 1997 Aug; 89(15):1164. PubMed ID: 9262256
[No Abstract] [Full Text] [Related]
8. [Acute respiratory distress syndrome after antineoplastic chemotherapy. Probable role of gemcitabine].
de Lavigerie B; Joasson JM
Presse Med; 2001 May 5-12; 30(17):851-4. PubMed ID: 11402938
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of radiation myositis probably induced by recall phenomenon].
Miura G; Matsumoto T; Tanaka N; Emoto T; Kawamura T; Matsunaga N
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep; 63(8):420-2. PubMed ID: 14587415
[TBL] [Abstract][Full Text] [Related]
10. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer.
Choi B; Robins HI; Schiller J; Mehta M
Cancer Chemother Pharmacol; 2008 Dec; 63(1):175-9. PubMed ID: 18305938
[TBL] [Abstract][Full Text] [Related]
12. Vasculitis due to gemcitabine.
Voorburg AM; van Beek FT; Slee PH; Seldenrijk CA; Schramel FM
Lung Cancer; 2002 May; 36(2):203-5. PubMed ID: 11955656
[TBL] [Abstract][Full Text] [Related]
13. [Gemcitabine: a new chemotherapy agent for solid cancers].
Klastersky J; Awada A
Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
[TBL] [Abstract][Full Text] [Related]
14. [Severe ischemic myopathy localized in an irradiated area following gemcitabine therapy].
Pariente A; Berthelémy P; Arotçarena R; Bénichou M; Calès V; Dujols JP
Presse Med; 2000 Oct; 29(30):1650. PubMed ID: 11089501
[No Abstract] [Full Text] [Related]
15. Gemcitabine-induced radiation recall dermatitis: case report.
Bar-Sela G; Beny A; Bergman R; Kuten A
Tumori; 2001; 87(6):428-30. PubMed ID: 11989599
[TBL] [Abstract][Full Text] [Related]
16. Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy.
Banach MJ; Williams GA
Arch Ophthalmol; 2000 May; 118(5):726-7. PubMed ID: 10815173
[No Abstract] [Full Text] [Related]
17. Gemcitabine-associated autonomic neuropathy.
Dormann AJ; Grünewald T; Wigginghaus B; Huchzermeyer H
Lancet; 1998 Feb; 351(9103):644. PubMed ID: 9500323
[No Abstract] [Full Text] [Related]
18. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer.
Anderson H; Hopwood P; Stephens RJ; Thatcher N; Cottier B; Nicholson M; Milroy R; Maughan TS; Falk SJ; Bond MG; Burt PA; Connolly CK; McIllmurray MB; Carmichael J
Br J Cancer; 2000 Aug; 83(4):447-53. PubMed ID: 10945489
[TBL] [Abstract][Full Text] [Related]
20. Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer.
Yildiz R; Coskun U; Kaya AO; Ozturk B; Yaman E
Ann Pharmacother; 2007 May; 41(5):901-2. PubMed ID: 17405819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
